Similarly, in metabolic disease models, PGG enhances insulin receptor activation and glucose uptake (Ren et al., 2006; Bruno et al., 2013), supporting its utility in glycemic regulation and diabetes management. The gene discussed is INSR; the disease is metabolic disease.